Showing results (71-80 of 237) with videos related to
Sort By:
Pageof 24
Journal of Oncology|June 25, 2009
[Not Available]Franziska Graf, Lena Koehler, Torsten Kniess, et al.Mini Reviews in Medicinal Chemistry|April 8, 2010
Cyclin-dependent kinase 4/6 (cdk4/6) inhibitors: perspectives in cancer therapy and imagingFranziska Graf, Birgit Mosch, Lena Koehler, et al.Chemmedchem|October 9, 2012
Fluorine-18 radiolabeling and radiopharmacological characterization of a benzodioxolylpyrimidine-based radiotracer targeting the receptor tyrosine kinase EphB4Constantin Mamat, Birgit Mosch, Christin Neuber, et al.Chemmedchem|April 6, 2013
An efficient bioorthogonal strategy using CuAAC click chemistry for radiofluorinations of SNEW peptides and the role of copper depletionMarc Pretze, Manuela Kuchar, Ralf Bergmann, et al.Inorganic Chemistry|July 4, 2013
Optimization of pentadentate bispidines as bifunctional chelators for 64Cu positron emission tomography (PET)Peter Comba, Sebastian Hunoldt, Michael Morgen, et al.Inorganic Chemistry|June 7, 2014
Bispidine dioxotetraaza macrocycles: a new class of bispidines for (64)Cu PET imagingPeter Comba, Manja Kubeil, Jens Pietzsch, et al.Molecules (Basel, Switzerland)|November 6, 2020
The Pyrazolo[3,4-<i>d</i>]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma XenograftsChristin Neuber, Alix Tröster, Reik Löser, et al.Medchemcomm|August 16, 2018
Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes - synthesis and COX-2 inhibition activitySilvia Roscales, Nicole Bechmann, Daniel Holger Weiss, et al.Pharmaceuticals (Basel, Switzerland)|March 8, 2014
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyWiebke Sihver, Jens Pietzsch, Mechthild Krause, et al.Medchemcomm|October 6, 2018
Correction: Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes - synthesis and COX-2 inhibition activitySilvia Roscales, Nicole Bechmann, Daniel Holger Weiss, et al.Pageof 24